United Kingdom· GB-APID-7971811000001100
Optiray 160 solution for infusion 50ml bottles
A ioversol product containing ioversol, registered in United Kingdom by Covidien (UK) Commercial Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ioversol is registered in 14 of 19 countries.
Countries holding a registration under ATC V08AB07 (ioversol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Ioversol · ATC V08AB07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ioversol
- Manufacturer
- Covidien (UK) Commercial Ltd
- Country
- United Kingdom (GB)
- ATC code
- V08AB07
- ATC class
- Ioversol
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
188 interactions on record for ioversol.
Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ioversol · interactions on record
188 records
- 94 severe
- 55 moderate
- 39 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ioversol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOptiject 240 mg I/mlGuerbet
- CzechiaOPTIRAYGuerbet, Roissy CdG Cedex
- Japanイオベルソールゲルベ・ジャパン
- FinlandOptirayMallinckrodt Medical GmbH
- SpainOPTIRAY 240 mg/ml SOLUCION INYECTABLEGuerbet
- United StatesOptirayLiebel-Flarsheim Company LLC
- SwedenOptiray (flerdos) 300 mg I/ml Injektions-/infusionsvätska, lösningGuerbet
- IrelandOptiray 300 mg I/ml PFS solution for injectionGuerbet
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Optiray
- Belgium · Optiject, Optiray
- Czechia · Optiray
- Germany · Optiray
- Denmark · Optiray
- Spain · Optiray, Optiray Ultraject
- Finland · Optiray
- France · Optiject, Optiray
- Greece · Optiray
- Croatia · Optiray
- Hungary · Optiray
- Ireland · Optiray
- Italy · Optiray
- Luxembourg · Optiject, Optiray
- Netherlands · Optiray
- Norway · Optiray
- Poland · Optiray
- Portugal · Optiray
- Romania · Optiray
- Sweden · Optiray
- Slovakia · Optiray
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aeef111c-d6a9-4e91-8089-957f75e99b00 GET /v1/drugs/aeef111c-d6a9-4e91-8089-957f75e99b00?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7971811000001100",
"desc": "Optiray 160 solution for infusion 50ml bottles (Covidien (UK) Commercial Ltd)",
"form": "Solution for infusion",
"vpid": "7971611000001104",
"source": "dmd",
"vtm_id": "776381000",
"strength": "160 mg",
"substance": "Ioversol",
"ingredient": "Ioversol",
"supplier_code": "3323211000001104"
}See everything about ioversol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.